|
1
|
Settin A, Dowaidar M, El-Baz R,
Abd-Al-Samad A, El-Sayed I and Nasr M: Frequency of factor V Leiden
mutation in Egyptian cases with myocardial infarction. Hematology.
13:170–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zöller B and Dahlbäck B: Linkage between
inherited resistance to activated protein C and factor V gene
mutation in venous thrombosis. Lancet. 343:1536–1538. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koster T, Rosendaal FR, de Ronde H, Briët
E, Vandenbroucke JP and Bertina RM: Venous thrombosis due to poor
anticoagulant response to activated protein C: Leiden Thrombophilia
Study. Lancet. 342:1503–1506. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamzi K, Tazzite A and Nadifi S:
Large-scale meta-analysis of genetic studies in ischemic stroke:
Five genes involving 152,797 ndividuals. Indian J Hum Genet.
17:212–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mannucci PM, Asselta R, Duga S, Guella I,
Spreafico M, Lotta L, Merlini PA, Peyvandi F, Kathiresan S and
Ardissino D: The association of factor V Leiden with myocardial
infarction is replicated in 1880 patients with premature disease. J
Thromb Haemost. 8:2116–2121. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boekholdt SM, Bijsterveld NR, Moons AH,
Levi M, Büller HR and Peters RJ: Genetic variation in coagulation
and fibrinolytic proteins and their relation with acute myocardial
infarction: A systematic review. Circulation. 104:3063–3068. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe
GD, Collins R and Danesh J: Seven haemostatic gene polymorphisms in
coronary disease: Meta-analysis of 66,155 cases and 91,307
controls. Lancet. 367:651–658. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim RJ and Becker RC: Association between
factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate
reductase C677T mutations and events of the arterial circulatory
system: A meta-analysis of published studies. Am Heart J.
146:948–957. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Juul K, Tybjaerg-Hansen A, Steffensen R,
Kofoed S, Jensen G and Nordestgaard BG: Factor V Leiden: The
Copenhagen City Heart Study and 2 meta-analyses. Blood. 100:3–10.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lucotte G and Mercier G: Population
genetics of factor V Leiden in Europe. Blood Cells Mol Dis.
27:362–367. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
They-They TP, Hamzi K, Moutawafik MT,
Bellayou H, El Messal M and Nadifi S: Prevalence of
angiotensin-converting enzyme, methylenetetrahydrofolatereductase,
Factor V Leiden, prothrombin and apolipoprotein E gene
polymorphisms in Morocco. Ann Hum Biol. 37:767–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mathonnet F, Nadifi S, Serazin-Leroy V,
Dakouane M and Giudicelli Y: Absence of factor V Leiden mutation
and low prothrombin G20210A mutation prevalence in a healthy
Moroccan population. Thromb Haemost. 88:1073–1074. 2002.PubMed/NCBI
|
|
13
|
Rosing J and Tans G: Coagulation factor V:
An old star shines again. Thromb Haemost. 78:427–433.
1997.PubMed/NCBI
|
|
14
|
van Wijk R, Nieuwenhuis K, van den Berg M,
Huizinga EG, van der Meijden BB, Kraaijenhagen RJ and van Solinge
WW: Five novel mutations in the gene for human blood coagulation
factor V associated with type I factor V deficiency. Blood.
98:358–367. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Diakite B, Hamzi K, Hmimech W and Nadifi
S: GMRAVC: First study of C2491T FV mutation with ischaemic stroke
risk in Morocco. J Genet. 94:313–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamzi K, Diakité B, Hmimech W and Nadifi
S: First study of the C2491t nonsense mutation frequency in
moroccan healthy population. J Mol Neurosci. 51:425–427. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dawson-Saunders B and Trapp RG: Basic and
clinical biostatistics (2nd). Appleton and Lange. Norwalk, CT:
1994.
|
|
18
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huber S, McMaster KJ and Voelkerding KV:
Analytical evaluation of primer engineered multiplex polymerase
chain reaction-restriction fragment length polymorphism for
detection of factor V Leiden and prothrombin G20210A. J Mol Diagn.
2:153–157. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perneger TV: What's wrong with Bonferroni
adjustments. BMJ. 316:1236–1238. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Delluc A, Le Ven F, Mottier D and Le Gal
G: Epidemiology and risk factors of venous thromboembolism. Rev Mal
Respir. 29:254–266. 2012.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bertina RM: Molecular risk factors for
thrombosis. Thromb Haemost. 82:601–609. 1999.PubMed/NCBI
|
|
23
|
Rosendaal FR: Risk factors for venous
thrombotic disease. Thromb Haemost. 82:610–619. 1999.PubMed/NCBI
|
|
24
|
Sakowicz A, Fendler W, Lelonek M and
Pietrucha T: Genetic variability and the risk of myocardial
infarction in Poles under 45 years of age. Arch Med Sci. 6:160–167.
2010b. View Article : Google Scholar
|
